Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Biallelic PAX5 mutations cause hypogammaglobulinemia, sensorimotor deficits, and autism spectrum disorder.
Kaiser FMP, Gruenbacher S, Oyaga MR, Nio E, Jaritz M, Sun Q, van der Zwaag W, Kreidl E, Zopf LM, Dalm VASH, Pel J, Gaiser C, van der Vliet R, Wahl L, Rietman A, Hill L, Leca I, Driessen G, Laffeber C, Brooks A, Katsikis PD, Lebbink JHG, Tachibana K, van der Burg M, De Zeeuw CI, Badura A, Busslinger M. Kaiser FMP, et al. Among authors: dalm vash. J Exp Med. 2023 Jan 2;220(1):e2022049812012022c. doi: 10.1084/jem.2022049812012022c. Epub 2022 Dec 7. J Exp Med. 2023. PMID: 36480208 Free PMC article. No abstract available.
Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
Hensley KS, Jongkees MJ, Geers D, GeurtsvanKessel CH, Mueller YM, Dalm VASH, Papageorgiou G, Steggink H, Gorska A, Bogers S, den Hollander JG, Bierman WFW, Gelinck LBS, Schippers EF, Ammerlaan HSM, van der Valk M, van Vonderen MGA, Delsing CE, Gisolf EH, Bruns AHW, Lauw FN, Berrevoets MAH, Sigaloff KCE, Soetekouw R, Branger J, de Mast Q, Lammers AJJ, Lowe SH, de Vries RD, Katsikis PD, Rijnders BJA, Brinkman K, Roukens AHE, Rokx C. Hensley KS, et al. Among authors: dalm vash. PLoS Med. 2023 Jan 6;20(1):e1004159. doi: 10.1371/journal.pmed.1004159. eCollection 2023 Jan. PLoS Med. 2023. PMID: 36608645 Free PMC article.
Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation.
Berbers RM, Paganelli FL, van Montfrans JM, Ellerbroek PM, Viveen MC, Rogers MRC, Salomons M, Schuurmans J, van Stigt Thans M, Vanmaris RMM, Brosens LAA, van der Wal MM, Dalm VASH, van Hagen PM, van de Ven AAJM, Uh HW, van Wijk F, Willems RJL, Leavis HL. Berbers RM, et al. Among authors: dalm vash. Microbiome. 2025 Jan 16;13(1):12. doi: 10.1186/s40168-024-01982-y. Microbiome. 2025. PMID: 39819634 Free PMC article.
Update on inborn errors of immunity.
IJspeert H, Edwards ESJ, O'Hehir RE, Dalm VASH, van Zelm MC. IJspeert H, et al. Among authors: dalm vash. J Allergy Clin Immunol. 2024 Dec 24:S0091-6749(24)02407-2. doi: 10.1016/j.jaci.2024.12.1075. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39724969 Free article. Review.
Exploring lymphocyte subsets in COVID-19 patients: insights from a tertiary academic medical center with a high proportion of patients on immunosuppression.
Daenen K, van Hooijdonk S, Tong-Minh K, Dik WA, van Hagen PM, Huijben JA, Gommers D, van Gorp ECM, Endeman H, Dalm VASH. Daenen K, et al. Among authors: dalm vash. Front Immunol. 2024 Dec 3;15:1436637. doi: 10.3389/fimmu.2024.1436637. eCollection 2024. Front Immunol. 2024. PMID: 39691720 Free PMC article.
A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis.
Rao VK, Šedivá A, Dalm VASH, Plebani A, Schuetz C, Shcherbina A, Trizzino A, Zharankova Y, Orpia A, Kulm E, Webster S, Körholz J, Lougaris V, Rodina Y, Conlon N, Coulter T, Bradt J, Relan A, Uzel G. Rao VK, et al. Among authors: dalm vash. Clin Immunol. 2025 Jan;270:110400. doi: 10.1016/j.clim.2024.110400. Epub 2024 Nov 17. Clin Immunol. 2025. PMID: 39561927 Free article. Clinical Trial.
Developing a Core Outcome Set for Netherton Syndrome: An International Multi-Stakeholder e-Delphi Consensus Study.
Nouwen AEM, Ragamin A, Knol MJ, Ott H, Weibel L, Has C, Hovnanian A, Paller AS, Bodemer C, Dalm VASH, Pasmans SGMA, Schappin R; all Netherton Syndrome Core Outcomes Research Evaluation (NSCORE) stakeholders. Nouwen AEM, et al. Among authors: dalm vash. Dermatology. 2024 Nov 1:1-14. doi: 10.1159/000542215. Online ahead of print. Dermatology. 2024. PMID: 39496226 Free article.
121 results